We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Nmc Health Plc | LSE:NMC | London | Ordinary Share | GB00B7FC0762 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 938.40 | 940.00 | 941.60 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
07/3/2019 07:32 | -- The Group remains confident with the guidance previously provided for FY 2019. To reiterate:o +22-24% YoY revenue growtho +18-20% YoY EBITDA growtho Excluding impact of acquisitions completed in 2018, FY 2019 revenue growth is anticipated to be 12-13% YoY and EBITDA growth approximately 15% YoYo Year-end net-debt to EBITDA to further reduce to 2.2-2.4xo 2019 guidance does not include impact of IFRS 16 implementation or the anticipated consolidation of National Medical Care Co.Management also remains confident with the longer-term Group EBITDA margin guidance of 25%. | steeplejack | |
07/3/2019 07:15 | Well done NMC Health Excellent year | tdog1975 | |
05/3/2019 07:59 | Good to see the JV 95% sorted pre results. Those need to be good to maintain the current price. | johnrxx99 | |
03/3/2019 22:55 | Cluster buying from bod ahead of results is one of the strongest buy signals you could wish for. If you are shorting this johnferro1 good luck you will need it. Note you are new poster on ADVN with all messages negative on this board only. Don’t find your profile very persuasive I’m afraid. RM | rampmeister | |
03/3/2019 19:05 | Don't hold the stock then! Stupid post! We don't need your apparent wisdom! | blocker2 | |
02/3/2019 19:11 | The company is publishing its full year 2018 results next week. Looks like it will beat its guidance as stated in its announcement. 2019 will be a challenging year for NMC with its Saudi investments looking terrible. It’s venture into Kenya doesn’t make sense. The mass exodus of the expat population from its home territory also adds to the growing number of woes. It’s record on corporate governance also is not encouraging. Worth taking a risk on this stock? | johnferro1 | |
09/2/2019 16:58 | One of the Directors have stepped down. She was part of couple of committees. Anything to do with the poor share performance? Of late, NMC has taken a lot of beating in the stock market. It is the only hospital in the region which still claims to achieve both topline and bottom growth year after year. During the last few years it had amassed too many assets which was sometimes perplexing. All other healthcare operators have stated that their growth both top and bottom line has come down. Can’t understand how NMC alone standout among the crowd! Trust, what they say are factual ones! | johnferro1 | |
24/1/2019 19:21 | 9m shares sold during the last 2 days! Everything fine with this company? Is there anything of major concern that investors are dumping this stock? | johnferro1 | |
24/1/2019 14:38 | The Capital Group Companies above 5% | mfhmfh | |
23/1/2019 12:21 | Huge vols yesterday and today. Over 5m yesterday and 3.7m so far today. 10x normal. | wildchild | |
16/1/2019 16:12 | Why the sudden drop? | blocker2 | |
14/1/2019 13:35 | nakedtrader.co.uk | mfhmfh | |
14/1/2019 12:45 | mfh How do you get onto his web site | jackdaw4243 | |
11/1/2019 19:20 | NMC Health and UDG Healthcare were given a bruising by Jefferies analysts on Friday, as they performed a check to the healthcare sector.With its premium rating, NMC was acknowledged as their "most anti-consensus" 'underperform' rating, with a price target of cut to 2,300p as the analysts "expect the market to increasingly focus on cash conversion and potential pressures in the base business in Abu Dhabi in the basic segment".UDG was downgraded to 'hold' from 'buy' and given a 620p target price as analysts expect market concerns around its Ashfield business to persist in 2019.The analysts believe Mediclinic "offers value", backed by a £3.2bn freehold property portfolio."Momentum stories" such as Hikma Pharma were highlighted and Dechra Pharma was suggested "for investors seeking non-cyclical stories". | steeplejack | |
11/1/2019 08:55 | NT bought more according to his website | mfhmfh | |
08/1/2019 05:58 | There are too many warning signs from this company. | johnferro1 | |
07/1/2019 18:26 | Any fall back tomorrow through profit taking will be my cue to buy back. May be jumping the gun but I think this has been oversold and is a fine company for medium to long term returns. | yertiz | |
04/1/2019 12:34 | I sold 2/3rds of my holding at £34.50 and kept the rest. I'm still in profit as these were all bought at between £12 and £18. I'm not concerned, nor smug, just waiting for the tide to turn before I buy back what I sold. The business is still good, sound and strong, the market is anything but. | yertiz | |
04/1/2019 12:12 | Probably because the Investors Chronicle heavily tipped the stock ten pounds higher up!Highly rated stocks are vulnerable in a bear market as bullish sentiment evaporates.Jeffries started the rot with a note that cut its share price target citing concerns about overexposure to Saudi Arabia.Coincidentall | steeplejack | |
04/1/2019 12:04 | Something internal that we don't know about. Can't wait to bounce back until it's too late. Be smart and cut losses. | startshare | |
04/1/2019 11:50 | Why is this in free fall? | dtaliadoros | |
03/1/2019 10:17 | No sign of recovery here, I am out. | startshare | |
27/12/2018 11:35 | NED bought approx. £148,000 of shares on 24.12.18 | mfhmfh | |
20/12/2018 11:13 | COO bought £49,365.30 worth yesterday. | mfhmfh |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions